JD Supra23d
FDA Approves First Rapid-Acting Insulin Biosimilar Product for the Treatment of Diabetes
On February 14, 2025, the U.S. Food and Drug Administration (“FDA”) approved Sanofi-Aventis U.S. LLC’s ... whereas insulin aspart is a rapid-acting human insulin analog that takes ...
FiercePharma25d
FDA signs off on Sanofi's insulin biosimilar, the first for Novo Nordisk's rapid-acting NovoLog
More than three years after approving two biosimilars referencing Sanofi’s long-acting insulin Lantus, the FDA has signed off on a rapid-acting insulin biosimilar for the first time. The agency ...
Pharmabiz26d
US FDA approves Sanofi-Aventis’ rapid-acting insulin biosimilar product Merilog for improvement of glycaemic control in patients with diabetes
Merilog, a rapid-acting human insulin analog ... The FDA granted approval of Merilog to Sanofi-Aventis U.S. LLC. “The FDA has now approved three biosimilar insulin products to treat diabetes,” said ...
Benzinga.com25d
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
is the first rapid-acting insulin biosimilar product approved by the FDA. Also Read: Sanofi/Johnson & Johnson Partnered Vaccine Against Bacterial Sepsis Flunks Late-Stage Study As a rapid-acting ...